A circular RNA (circRNA) drug enhanced saliva production in radiation-induced xerostomia, a promising development in the ...

I’ve been poring over the news around Intellia Therapeutics’ NTLA-2001, an in vivo CRISPR-Cas9 therapy to inactivate the TTR gene in two sets of transthyretin amyloidosis patients. On October 27, 2025 ...

NeoCOAST-2 trial finds early ctDNA clearance in blood tests linked to improved lung cancer outcomes, potentially guiding ...

Phase III findings suggest a promising option for women whose endometrial cancer progresses despite prior chemotherapy and ...

Europe has world-class biotech research, but can it scale? Nordic Life Science Days explores the capital, expertise, and ...

Researchers have developed an AI-powered personal health agent created as an open-source multi-agent framework for dynamic, personalized health interactions.

From whole-genome sequencing to magnetic resonance imaging (MRI) and artificial intelligence (AI)-guided diagnostics, these ...

Antibody patterns can signal whether a person will develop inflammatory bowel disease (IBD) up to 10 years before diagnosis.

GLP-1 medications may reduce complications after surgery, with new research linking their use to fewer cardiovascular events ...

New research reveals how autoimmune kidney inflammation develops and identifies an antibody-based strategy that may prevent ...

New research links genomic, transcriptomic, and epigenetic features to treatment response in multiple myeloma.

The U.K. biotech IMU Biosciences will help create a large and detailed immune dataset for 80,000 people in the UK Biobank.